ArticleProceedings of the National Academy of Sciences of the United States of America2013

Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.

Julie Quoyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.